Understanding LucenceINSIGHT™ PLUS
Cancer is often most treatable when detected early. 4 out of 5 cancer deaths are from cancers not covered by routine screenings, such as breast, colorectal, and cervical cancers. 3-4 Many common and deadly cancers lack effective screening methods.
LucenceINSIGHT™ PLUS builds upon the groundbreaking liquid biopsy for cancer, analyzing circulating tumor DNA (ctDNA) in your blood. This ctDNA carries vital clues about cancer, even in its earliest stages, allowing for detection before symptoms appear.
Instead of invasive tissue biopsies, LucenceINSIGHT™ PLUS requires a simple blood test for early cancer detection, making it a convenient and comfortable screening option.
Why Get Cancer Screening Blood Tests Early?
- 5-year survival rates are significantly higher when cancer is detected and treated early.
- Breast, lung, bronchus, prostate, and colorectal cancers account for almost 50% of all new cancer cases in the United States, responsible for nearly 50% of all deaths. 2
- Cancer deaths in the United States are the leading cause of death for those under 65 years of age. 2
LucenceINSIGHT™ PLUS vs Other Cancer Marker Tests
CEA, CA19-9, and CA-125 are traditional cancer marker tests measuring specific blood proteins. However, these tests have notable limitations. They exhibit low sensitivity and specificity, leading to false positives, and early-stage cancers may also be undetectable, resulting in false negatives.
Additionally, these markers are primarily utilized to track known cancers or to detect the recurrence of certain cancer types, which limits their use for comprehensive multi-cancer screening and early detection in individuals who do not show symptoms.
LucenceINSIGHT™ PLUS offers several advantages in early detection of cancer:
- Enhanced Detection: ctDNA testing is more sensitive and specific than traditional markers, allowing for high accuracy and earlier detection of cancer-related DNA.
- Comprehensive Screening: LucenceINSIGHT™ offers multi-cancer screenings, increasing the likelihood of identifying potential malignancies.
- Early Detection Potential: ctDNA can be found in blood before symptoms emerge, enabling earlier cancer detection and improving treatment success.
- Noninvasive Nature: LucenceINSIGHT™ requires only a simple blood draw, making cancer screening comfortable and convenient without biopsies.
Evidence Supporting LucenceINSIGHT™
Recent studies have demonstrated the effectiveness of LucenceINSIGHT™ in real-world settings. A 2023 study of 264 asymptomatic individuals found a 100% positive predictive value (PPV), meaning a positive result reliably indicates the presence of cancer.
Additionally, a 2024 study with 601 patient samples showed LucenceINSIGHT™ has 81% sensitivity and 99% specificity, demonstrating its effectiveness in correctly identifying cancer while reducing false positives.
What Cancers Can LucenceINSIGHT™ PLUS Screen For?
LucenceINSIGHT™ PLUS is designed to detect up to 50 types of cancer, including some of the most common and aggressive types.
Is LucenceINSIGHT™ PLUS for You?
You might be a candidate for LucenceINSIGHT™ PLUS if you:
- Have a family history of cancer
- Are concerned about your general cancer risk
- Asymptomatic patients seeking a comprehensive and convenient cancer screening solution
- Are proactive about your health and well-being
Disclaimer: LucenceINSIGHT™ PLUS is a screening test, not a diagnostic testing substitute. It does not predict inherited cancer risk. Consult your doctor to discuss your risk factors and determine if LucenceINSIGHT™ PLUS suits you.
The LucenceINSIGHT™ PLUS Process
- Join Mito Health: Sign up and complete our health and lifestyle questionnaire. Then, book a LucenceInsight™ test directly on your Mito dashboard.
- Choose your Blood Draw Location: You can choose from one of more than 2,000 LabCorp locations in the United States or BioReference labs in New York, New Jersey, or Rhode Island.
- Blood Draw: A simple blood draw is performed at our convenient location. The procedure is quick, minimally invasive, and requires no special preparation.
- Comprehensive Report: In 18 working days, you'll receive a detailed, easy-to-understand report outlining your results.
- Results Discussion: Our team of top doctors will review your report with you, explain the findings, and recommend any necessary next steps.
Why Choose Mito Health for the LucenceINSIGHT™ PLUS Test?
At Mito Health, we offer comprehensive lab tests, including blood tests to detect cancer early to help you get the most in-depth picture of your health. Our top doctors create a personalized health action plan with tailored recommendations based on your LucenceINSIGHT™ PLUS test results.
